Cholesteryl ester transfer protein gene expression is not specifically regulated by CCAAT/Enhancer-binding protein in HepG2-cells

Atherosclerosis

Volumn 146, Issue 1, 1999, Pages 11-18

  Ritsch, Andreas ^a   Doppler, Wolfgang ^a   Pfeifhofer, Christa ^a   Sandhofer, Anton ^a   Bodner, Johannes ^a   Patsch, Josef R ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

CETP gene expression; CETP promoter; CETP synthesis; Electromobility shift assay; Neutral lipid transfer; Quantification of CETP; Transcription factor; Transcriptional regulation; Transient transfection

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL STRAIN CACO 2; CONSENSUS SEQUENCE; ENHANCER REGION; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; TRANSCRIPTION REGULATION;

APOLIPOPROTEINS; BASE SEQUENCE; BETA-GALACTOSIDASE; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CHOLESTEROL ESTER TRANSFER PROTEINS; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; LIVER; LUCIFERASES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0032779329     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00107-0     Document Type: Article

References (43)

1. Albers JJ, Tollefson JH, Chen CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 1984;4:49-58.
2. Jarnagin AS, Kohr W, Fielding CJ. Isolation and specificity of a Mr 74000 cholesteryl ester transfer protein from human plasma. Proc Natl Acad Sci USA 1987;84:1854-7.
3. Barter PJ, Hopkins G, Calvert GD. Transfers and exchanges of esterified cholesterol between plasma lipoproteins. Biochem J 1982;208:1-7.
4. Hesler CB, Swenson TL, Tall AR. Purification and characterization of human cholesteryl ester transfer protein. J Biol Chem 1987;262:2275-82.
5. Morton RE, Zilversmit DB. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J Lipid Res 1982;23:1058-67.
6. Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, Fielding CJ, Lawn R. Cloning and sequencing of the human cholesteryl ester transfer protein cDNA. Nature 1987;327:632-4.
7. Jiang XC, Moulin P, Quinet E, Goldberg IJ, Yacoub LK, Agellon LB, Compton D, Schnitzer-Polokoff R, Tall AR. Mammalian adipose tissue and muscle are the major source of lipid transfer protein mRNA. J Biol Chem 1991;266:4631-9.
8. Swenson TL, Simmons JS, Hesler CB, Bisgaier C, Tall AR. Cholesteryl ester transfer protein is secreted by Hep G2 cells and contains asparagine-linked carbohydrate and sialic acid. J Biol Chem 1987;262:16271-4.
9. Faust RA, Albers JJ. Synthesis and secretion of plasma cholesteryl ester transfer protein by human hepatocarcinoma cell line, HepG2. Arteriosclerosis 1987;7:267-75.
10. Faust RA, Albers JJ. Regulated vectorial secretion of cholesteryl ester transfer protein (LTP-I) by the CaCo-2 model of human enterocyte epithelium. J Biol Chem 1988;263:8786-9.
11. McPherson R, Hogue M, Milne RW, Tall AR, Marcel YL. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Arteriosclerosis 1991;11:476-81.
12. Föger B, Drexel H, Hopferwieser T, Miesenboeck G, Ritsch A, Lechleitner M, Tröbinger G, Patsch JR. Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia. Clin Invest 1994;72:294-301.
13. Föger B, Pfeiffer KP, Ritsch A, Tröbinger G, Hopferwieser T, Patsch JR. Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein composition, lipoprotein-modifying enzymes and postprandial lipoprotein metabolism. Atherosclerosis 1994;109:128 Abstr.
14. Bhatnagar D, Durrington PN, Mackness MI, Arrol S, Winocour PH, Prais H. Effects of treatment of hypertriglyceridemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl esters from high density lipoproteins to low density lipoproteins. Atherosclerosis 1992;92:49-57.
15. Dullaart RP, Hoogenberg K, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins. Eur J Clin Invest 1990;20:581-7.
16. Foger B, Konigsrainer A, Palos G, Ritsch A, Trobinger G, Menzel HJ, Lechleitner M, Doblinger A, Konig P, Utermann G, Margreiter R, Patsch JR. Effects of pancreas transplantation on distribution and composition of plasma lipoproteins. Metabolism 1996;45:856-61.
17. Moulin P, Appell GB, Ginsberg N, Tall AR. Increased concentration of cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia. J Lipid Res 1992;33:1817-22.
18. Silliman K, Tall AR, Kretchmer N, Forte TM. Unusual high-density lipoprotein subclass distribution during late pregnancy. Metabolism 1993;42:1592-9.
19. Föger B, Wohlfarter T, Ritsch A, Lechleitner M, Miller CH, Dienstl A, Patsch JR. Kinetics of lipids, apolipoproteins, and cholesteryl ester transfer protein in plasma after a bicycle marathon. Metabolism 1994;43:633-9.
20. Hannuksela M, Marcel YL, Kesäniemi A, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992;33:737-44.
21. Groener JEM, Jacobs DMLHA, van Rozen AJ, Erkelens DW. Diet, lipoproteins and cholesteryl ester transfer activity in hyperlipidemic subjects. Clin Nutr 1985;4:35-8.
22. Groener JEM, van Ramshorst EM, Katan MB, Mensink RB, von Tol A. Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects. Atherosclerosis 1991;87:221-6.
23. Gaudet F, Ginsburg GS. Transcriptional regulation of the cholesteryl ester transfer protein gene by the orphan nuclear hormone receptor apolipoprotein AI regulatory protein-1. J Biol Chem 1995;270:29916-22.
24. Agellon LB, Zhang P, Jiang XC, Mendelsohn L, Tall AR. The CCAAT/Enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter. J Biol Chem 1992;267:22336-9.
25. Graves BJ, Johnson PF, McKnight SL. Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene. Cell 1986;44:565-76.
26. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 1992;127:25-50.
27. Umek RM, Friedman AD, McKnight SL. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 1991;251:288-92.
28. ™ reagent. In: Murray EJ, editor. Methods in Molecular Biology. Clifton, NJ: Humana, 1991:81-9.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
30. Ritsch A, Drexel H, Amann FW, Pfeifhofer C, Patsch JR. Deficiency of cholesteryl ester transfer protein due to a novel molecular defect: Dissociation of transport of cholesteryl esters and triglycerides in plasma. Arterioscler Thromb Vasc Biol 1997;17:3433-41.
31. Antonson P, Xanthopoulos KG. Molecular cloning, sequence, and expression patterns of the human gene encoding CCAAT/ enhancer binding protein alpha (C/EBP alpha). Biochem Biophys Res Commun 1995;215:106-13.
32. Luckow B, Schuetz G. CAT constructs with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res 1987;15:5490.
33. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
34. Klocker H, Kaspar F, Eberle J, Bartsch G. Isolation and direct sequencing of PCR-cDNA fragments from tissue biopsies. In: Rolfs A, Schuller I, Finckh U, Weber-Rolfs I, editors. PCR: Clinical Diagnostics and Research. Berlin: Springer, 1992.
35. Sears RC, Sealy L. Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat (published erratum appears in Mol Cell Biol 1994;14(8):5617). Mol Cell Biol 1994;14:4855-71.
36. Clark RW, Moberly JB, Bamberger MJ. Low level quantification of cholesteryl ester transfer protein in plasma subfractions and cell culture media by monoclonal antibody-based immunoassay. J Lipid Res 1995;36:876-89.
37. Doppler W, Welte T, Philipp S. CCAAT/enhancer-binding protein isoforms beta and delta are expressed in mammary epithelial cells and bind to multiple sites in the beta-casein gene promoter. J Biol Chem 1995;270:17962-9.
38. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991;5:1538-52.
39. de la Brousse FC, Shan B, Chen JL. Identification of the promoter of the mouse obese gene. Proc Natl Acad Sci USA 1996;93:4096-101.
40. Fernandez Rachubinski FA, Weiner JH, Blajchman MA. Regions flanking exon 1 regulate constitutive expression of the human antithrombin gene. J Biol Chem 1996;271:29502-12.
41. Park EA, Song S, Olive M, Roesler WJ. CCAAT-enhancer-binding protein alpha (C/EBP alpha) is required for the thyroid hormone but not the retinoic acid induction of phosphoenolpyruvate carboxykinase (PEPCK) gene transcription. Biochem J 1997;322:343-9.
42. Seo SJ, Kim HT, Cho G, Rho HM, Jung G. Sp1 and C/EBP-related factor regulate the transcription of human Cu/Zn SOD gene. Gene 1996;178:177-85.
43. Jiang XC, Agellon LB, Walsh A, Breslow JL, Tall AR. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice: dependence on natural flanking sequences. J Clin Invest 1992;90:1290-5.